PAIELLA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 12.321
EU - Europa 11.259
AS - Asia 7.963
SA - Sud America 1.159
AF - Africa 302
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 4
Totale 33.040
Nazione #
US - Stati Uniti d'America 11.996
RU - Federazione Russa 4.652
SG - Singapore 3.144
CN - Cina 2.082
IT - Italia 1.790
GB - Regno Unito 1.437
BR - Brasile 936
HK - Hong Kong 781
DE - Germania 713
VN - Vietnam 694
SE - Svezia 543
FR - Francia 514
IE - Irlanda 508
FI - Finlandia 278
BD - Bangladesh 269
KR - Corea 233
NL - Olanda 227
CA - Canada 181
IN - India 175
JP - Giappone 121
ES - Italia 114
MX - Messico 95
UA - Ucraina 89
AR - Argentina 80
TR - Turchia 76
ZA - Sudafrica 69
AT - Austria 66
PL - Polonia 64
IQ - Iraq 58
ID - Indonesia 57
NG - Nigeria 53
CZ - Repubblica Ceca 45
TG - Togo 38
BE - Belgio 37
PK - Pakistan 36
BJ - Benin 33
AU - Australia 28
EC - Ecuador 27
CO - Colombia 25
LT - Lituania 25
CH - Svizzera 24
NP - Nepal 24
UZ - Uzbekistan 24
VE - Venezuela 24
MA - Marocco 23
SA - Arabia Saudita 23
EG - Egitto 20
TN - Tunisia 20
PH - Filippine 19
PY - Paraguay 18
CL - Cile 17
IL - Israele 17
JO - Giordania 16
RO - Romania 14
IR - Iran 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
AZ - Azerbaigian 12
KE - Kenya 12
HR - Croazia 11
HU - Ungheria 11
DK - Danimarca 10
LV - Lettonia 10
PT - Portogallo 10
GR - Grecia 9
KG - Kirghizistan 9
BO - Bolivia 8
KZ - Kazakistan 8
UY - Uruguay 8
CR - Costa Rica 7
ET - Etiopia 7
JM - Giamaica 7
LB - Libano 7
MY - Malesia 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
GT - Guatemala 6
NO - Norvegia 6
PA - Panama 6
RS - Serbia 6
BG - Bulgaria 5
DZ - Algeria 5
GE - Georgia 5
OM - Oman 5
PR - Porto Rico 5
SI - Slovenia 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GA - Gabon 4
GH - Ghana 4
HN - Honduras 4
PS - Palestinian Territory 4
CY - Cipro 3
EE - Estonia 3
GY - Guiana 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
Totale 32.988
Città #
Dallas 2.280
Moscow 1.733
Singapore 1.649
Ashburn 1.463
San Jose 1.159
Southend 1.107
Chandler 1.086
Hong Kong 769
Verona 619
Dublin 485
Beijing 394
Council Bluffs 340
New York 329
The Dalles 305
Los Angeles 282
Ho Chi Minh City 251
Woodbridge 239
Jacksonville 231
Munich 227
Houston 203
Ann Arbor 169
Hanoi 159
Lawrence 150
Princeton 150
Boardman 140
Helsinki 135
Wilmington 133
Jinan 115
Orem 115
Santa Clara 112
Milan 109
São Paulo 108
Buffalo 104
Tokyo 100
Nanjing 95
Shenyang 90
Redondo Beach 87
London 79
Seattle 75
Sindelfingen 75
Amsterdam 72
Montreal 72
Turku 63
Columbus 62
Rome 62
Redmond 61
Frankfurt am Main 59
Tianjin 59
Chennai 56
Hebei 55
Denver 52
Toronto 52
Hangzhou 51
Warsaw 51
Bologna 50
Abuja 47
Stockholm 46
Atlanta 45
Johannesburg 44
San Francisco 44
Fairfield 43
Chicago 42
Haikou 42
Ningbo 40
Nuremberg 40
Phoenix 40
Zhengzhou 40
Brooklyn 38
Changsha 38
Lomé 38
Washington 38
Falkenstein 35
Seoul 35
Manchester 34
Redwood City 34
Cotonou 33
Guangzhou 33
Mexico City 33
Brussels 32
Nanchang 32
Vienna 32
Poplar 31
Brno 30
Da Nang 30
Mumbai 30
Taizhou 30
Lappeenranta 29
Taiyuan 29
Belo Horizonte 28
Boston 27
Paris 26
Meda 25
Rio de Janeiro 25
Falls Church 24
Jakarta 24
Barnet 22
Jiaxing 22
City of London 21
Haiphong 21
Tashkent 21
Totale 19.821
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 953
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 335
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe 293
Diffusion of Robotic Platforms and New Devices in HPB Surgery: A European-African Hepato-Pancreato-Biliary Association (E-AHPBA) Survey 276
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 267
A rare case of three different tumors in the same pancreatic specimen: a case report and brief review of the literature 259
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 258
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 250
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 248
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 241
Gα15 in early onset of pancreatic ductal adenocarcinoma 239
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 238
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 237
7T MRI and histology reveal early tissue and perfusion changes after radiofrequency ablation in a murine colorectal cancer model 236
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
A root-cause analysis of mortality following major pancreatectomy 228
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 220
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 218
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 218
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 216
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 215
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 213
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 212
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 212
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 210
Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay 210
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 206
Delaying surgery for patients with a previous SARS-CoV-2 infection 204
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 203
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 200
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 197
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 195
Sex differences in oncogenic mutational processes 195
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 194
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 193
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 190
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Ablation treatments in unresectable pancreatic cancer 185
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation 184
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 184
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 183
Can CT texture analysis predict resectability and surgical outcomes after neoadjuvant radiotherapy in pancreatic cancer patients? 183
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 180
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 179
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 178
Fhit down-regulation is an early event in pancreatic carcinogenesis 177
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 176
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 175
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer 175
Cytoreduction after radiofrequency ablation of unresectable pancreatic adenocarcinoma: correlation between CA 19.9 serum levels and necrosis extent at CT 174
Solid-pseudopapillary, Acinar, and Other Cystic Neoplasms 174
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 174
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar 174
Minimally invasive pancreatic surgery - a review 173
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma 173
Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors 173
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 171
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 171
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 170
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 169
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 167
The management of intraductal papillary mucinous neoplasms of the pancreas 167
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries 167
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 166
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis 166
Long term outcome after minimally invasive and open Warshaw and Kimura techniques for spleen-preserving distal pancreatectomy: International multicenter retrospective study 166
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 165
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 165
Modified Frailty Index to Assess Risk in Elderly Patients Undergoing Distal Pancreatectomy: A Retrospective Single-Center Study 165
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 164
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 164
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 163
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 163
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 163
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma 163
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 161
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 160
ESGAR 2018 Book of Abstracts 159
Local ablation disrupts immune evasion in pancreatic cancer 158
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 158
Laser Treatment of Pancreatic Cancer with Immunostimulating Interstitial Laser Thermotherapy Protocol: Safety and Feasibility Results From Two Phase 2a Studies 158
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 158
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 157
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 156
An Antibiotic Stewardship Program in Pancreatic Surgery 156
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 155
Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial 155
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 155
Percutaneous ablation of pancreatic cancer 152
Le terapie ablative delle neoplasie pancreatiche 152
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 152
The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis 151
Surgery for Distal Cholangiocarcinoma 150
Totale 19.976
Categoria #
all - tutte 112.379
article - articoli 106.895
book - libri 0
conference - conferenze 1.939
curatela - curatele 0
other - altro 336
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.209
Totale 224.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 0 76
2021/20221.147 123 256 12 75 45 43 46 69 75 36 87 280
2022/20233.444 187 400 251 573 283 964 96 214 335 34 62 45
2023/20241.995 56 144 201 219 204 329 108 144 32 98 354 106
2024/20255.118 283 273 232 776 269 153 326 282 671 370 522 961
2025/202618.034 1.032 1.140 2.035 2.710 4.114 1.074 1.446 1.006 1.411 1.021 429 616
Totale 33.404